Table 1.

Baseline clinical features, clinical complains and laboratoryfindingsof our study cohort.

	Whole population (n = 180)	Acute pericarditis (n = 39)	No acute pericarditis (n = 141)	P value
Baseline features
Age (years)	48 ± 16	45 ± 14	48 ± 16	0.320
Sex (female)	112 (62)	31 (80)	81 (57)	0.0120
Hypertension, (%)	30 (17)	4 (10)	26 (18)	0.201
Diabetes	4 (2)	1 (3)	3 (2)	0.870
Dyslipidemia	11 (6)	3 (7)	8 (6)	0.641
Coronary artery disease	4 (2)	1 (3)	3 (2)	0.870
Impaired renal function	4 (2)	0(0)	4 (3)	0.288
Asthma/Chronic obstructive pulmonary disease	10 (6)	3 (8)	7 (5)	0.510
Autoimmune and allergic disorders	29 (16)	15 (38)	14 (10)	<0.0001
Duration of positivity at SARS-CoV2 test (days)	21 [14–41]	19 [14–41]	22 [14–32]	0.6997
Duration of symptoms (days)	131 [94–255]	166 [116–255]	122[94–183]	0.0106
Prior COVID-19 vaccination (%)	68 (38)	22 (56)	46 (33)	0.00670
Prior COVID-19 hospitalization	23 (13)	1 (3)	22 (16)	0.0310
Emergency department visits	34 (19)	5 (13)	29 (21)	0.274
Oxygen desaturation during COVID-19	37 (21)	3 (8)	34 (24)	0.0247
Temperature > 38 °C during COVID-19	62 (34)	8 (21)	54 (38)	0.0386
Clinical complaints
Brain fog/lack of concentration (%)	18 (10)	5 (13)	13 (9)	0.507
Chest pain/discomfort	61 (34)	35 (90)	26 (18)	<0.0001
Cough	19 (11)	4 (10)	15 (11)	0.945
Headache	7 (4)	1 (3)	6 (4)	0.629
Heart palpitations/arrhythmias	66 (37)	26 (67)	40 (28)	<0.0001
Shortness of breath/fatigue	93 (52)	13 (33)	80 (57)	0.00964
Other symptoms	41 (23)	10 (26)	31 (22)	0.573
Laboratory analyses
Abnormal C reactive protein (%)	18 (10)	8 (21)	9 (6)	0.00101
Abnormal erythrocyte sedimentation rate	16 (9)	10 (26)	6 (4)	<0.0001
Abnormal D dimer	17 (9)	4 (10)	13 (9)	0.845